mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.02 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |